 Lorna Browne
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 33 | 2025 | 3397 | 3.830 |
Why?
| | Tomography, X-Ray Computed | 18 | 2024 | 2511 | 3.100 |
Why?
| | Magnetic Resonance Angiography | 9 | 2025 | 234 | 2.020 |
Why?
| | Vascular Stiffness | 12 | 2024 | 467 | 1.850 |
Why?
| | Heart Defects, Congenital | 7 | 2023 | 796 | 1.730 |
Why?
| | Magnetic Resonance Imaging, Cine | 12 | 2024 | 186 | 1.690 |
Why?
| | Aortic Coarctation | 5 | 2025 | 83 | 1.640 |
Why?
| | Hemodynamics | 17 | 2024 | 1094 | 1.540 |
Why?
| | Hypertension, Pulmonary | 9 | 2024 | 1897 | 1.360 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 4 | 2022 | 92 | 1.360 |
Why?
| | Aorta | 12 | 2024 | 408 | 1.160 |
Why?
| | Computed Tomography Angiography | 5 | 2023 | 115 | 1.140 |
Why?
| | Pulmonary Artery | 12 | 2024 | 1097 | 1.110 |
Why?
| | Coronary Vessels | 5 | 2022 | 239 | 1.100 |
Why?
| | Child | 53 | 2024 | 20962 | 1.070 |
Why?
| | Imaging, Three-Dimensional | 9 | 2025 | 530 | 0.960 |
Why?
| | Infant | 26 | 2024 | 9018 | 0.960 |
Why?
| | Retrospective Studies | 33 | 2024 | 14553 | 0.910 |
Why?
| | Infant, Newborn | 20 | 2024 | 5772 | 0.900 |
Why?
| | Heart | 5 | 2023 | 645 | 0.870 |
Why?
| | Child, Preschool | 23 | 2024 | 10522 | 0.830 |
Why?
| | Blood Flow Velocity | 9 | 2024 | 406 | 0.820 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.810 |
Why?
| | Pulmonary Valve | 3 | 2024 | 93 | 0.810 |
Why?
| | Tetralogy of Fallot | 5 | 2022 | 78 | 0.800 |
Why?
| | Coronary Circulation | 3 | 2022 | 139 | 0.780 |
Why?
| | Pulmonary Veins | 1 | 2023 | 98 | 0.760 |
Why?
| | Heart Ventricles | 8 | 2023 | 781 | 0.760 |
Why?
| | Humans | 89 | 2025 | 129847 | 0.700 |
Why?
| | Adolescent | 37 | 2024 | 20451 | 0.690 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 19 | 0.680 |
Why?
| | Body Surface Area | 1 | 2020 | 33 | 0.680 |
Why?
| | Aorta, Thoracic | 5 | 2023 | 263 | 0.680 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2020 | 385 | 0.670 |
Why?
| | Foreign Bodies | 1 | 2021 | 103 | 0.660 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2024 | 177 | 0.640 |
Why?
| | Anesthesia | 1 | 2022 | 172 | 0.630 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 529 | 0.600 |
Why?
| | Osteomyelitis | 2 | 2012 | 121 | 0.580 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 326 | 0.580 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.580 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 378 | 0.570 |
Why?
| | Pulse Wave Analysis | 7 | 2022 | 248 | 0.560 |
Why?
| | Male | 49 | 2024 | 63759 | 0.550 |
Why?
| | Postoperative Complications | 5 | 2020 | 2481 | 0.550 |
Why?
| | Female | 50 | 2025 | 68829 | 0.540 |
Why?
| | Echocardiography | 6 | 2023 | 636 | 0.520 |
Why?
| | Predictive Value of Tests | 7 | 2025 | 1951 | 0.520 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 9 | 0.510 |
Why?
| | Bronchiolitis | 1 | 2017 | 90 | 0.510 |
Why?
| | Heart Rate | 1 | 2020 | 804 | 0.510 |
Why?
| | Arteries | 1 | 2018 | 266 | 0.510 |
Why?
| | Hemoptysis | 1 | 2016 | 35 | 0.500 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 109 | 0.490 |
Why?
| | Ultrasonography | 3 | 2015 | 713 | 0.480 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 391 | 0.480 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.480 |
Why?
| | Lung Diseases, Interstitial | 2 | 2019 | 611 | 0.470 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 231 | 0.470 |
Why?
| | Scrotum | 1 | 2015 | 26 | 0.470 |
Why?
| | Image Enhancement | 2 | 2022 | 168 | 0.470 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.460 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.460 |
Why?
| | Myocardium | 2 | 2017 | 983 | 0.450 |
Why?
| | Testis | 1 | 2015 | 144 | 0.450 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 102 | 0.430 |
Why?
| | Preoperative Care | 2 | 2017 | 337 | 0.430 |
Why?
| | Fetal Heart | 2 | 2024 | 55 | 0.430 |
Why?
| | Radiation Dosage | 3 | 2024 | 154 | 0.420 |
Why?
| | Phantoms, Imaging | 2 | 2024 | 137 | 0.420 |
Why?
| | Stress, Mechanical | 5 | 2024 | 467 | 0.420 |
Why?
| | Fontan Procedure | 3 | 2020 | 175 | 0.420 |
Why?
| | Arterial Pressure | 3 | 2019 | 119 | 0.410 |
Why?
| | Heart Valve Diseases | 3 | 2024 | 152 | 0.410 |
Why?
| | Anesthesia, General | 2 | 2024 | 60 | 0.410 |
Why?
| | Community-Acquired Infections | 2 | 2012 | 160 | 0.390 |
Why?
| | Regional Blood Flow | 3 | 2024 | 463 | 0.380 |
Why?
| | Growth Plate | 1 | 2012 | 36 | 0.370 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2011 | 20 | 0.360 |
Why?
| | Young Adult | 15 | 2024 | 12467 | 0.360 |
Why?
| | Contrast Media | 4 | 2025 | 394 | 0.350 |
Why?
| | Intestinal Obstruction | 1 | 2011 | 49 | 0.350 |
Why?
| | Aortic Valve | 3 | 2024 | 348 | 0.350 |
Why?
| | Peritonitis | 1 | 2011 | 81 | 0.350 |
Why?
| | Lung Diseases | 2 | 2014 | 743 | 0.340 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2020 | 121 | 0.330 |
Why?
| | Coronary Angiography | 2 | 2022 | 306 | 0.330 |
Why?
| | Radiology | 2 | 2022 | 159 | 0.330 |
Why?
| | Aortic Diseases | 3 | 2020 | 114 | 0.330 |
Why?
| | Myocardial Stunning | 1 | 2009 | 5 | 0.330 |
Why?
| | Postoperative Care | 1 | 2011 | 244 | 0.330 |
Why?
| | Cardiac Surgical Procedures | 3 | 2020 | 509 | 0.320 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 33 | 0.320 |
Why?
| | Cardiology | 2 | 2022 | 266 | 0.320 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3089 | 0.320 |
Why?
| | Aortic Arch Syndromes | 1 | 2009 | 2 | 0.320 |
Why?
| | Fetus | 3 | 2025 | 782 | 0.320 |
Why?
| | Radiography, Abdominal | 2 | 2024 | 46 | 0.300 |
Why?
| | Heart Diseases | 2 | 2022 | 352 | 0.300 |
Why?
| | Diagnosis, Differential | 5 | 2018 | 1434 | 0.300 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2008 | 3 | 0.300 |
Why?
| | Ultrasonography, Prenatal | 3 | 2025 | 276 | 0.290 |
Why?
| | Turner Syndrome | 2 | 2019 | 51 | 0.290 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 276 | 0.290 |
Why?
| | Puberty, Precocious | 1 | 2008 | 13 | 0.290 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 77 | 0.290 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 175 | 0.290 |
Why?
| | Cardiovascular Diseases | 5 | 2025 | 2008 | 0.280 |
Why?
| | Hypothyroidism | 1 | 2008 | 70 | 0.280 |
Why?
| | Ovary | 1 | 2008 | 209 | 0.250 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2025 | 252 | 0.250 |
Why?
| | Cardiac Catheterization | 5 | 2024 | 520 | 0.250 |
Why?
| | Perfusion Imaging | 3 | 2024 | 56 | 0.250 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 221 | 0.240 |
Why?
| | Risk | 2 | 2018 | 860 | 0.240 |
Why?
| | Artifacts | 2 | 2025 | 127 | 0.240 |
Why?
| | Biopsy | 3 | 2018 | 1089 | 0.240 |
Why?
| | Greenhouse Gases | 1 | 2025 | 11 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2024 | 3630 | 0.230 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2024 | 8 | 0.230 |
Why?
| | Cross-Over Studies | 2 | 2024 | 521 | 0.230 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 40 | 0.230 |
Why?
| | Infant, Premature | 2 | 2023 | 541 | 0.230 |
Why?
| | Respiration | 2 | 2022 | 193 | 0.230 |
Why?
| | Treatment Outcome | 12 | 2024 | 10241 | 0.220 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 108 | 0.220 |
Why?
| | Gestational Age | 2 | 2024 | 876 | 0.210 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 96 | 0.210 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2024 | 199 | 0.200 |
Why?
| | Virtual Reality | 1 | 2024 | 53 | 0.200 |
Why?
| | Prenatal Diagnosis | 1 | 2025 | 196 | 0.200 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.200 |
Why?
| | Pancreatitis, Chronic | 1 | 2023 | 51 | 0.200 |
Why?
| | Heart Valve Prosthesis | 1 | 2024 | 113 | 0.200 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.200 |
Why?
| | Hepatic Veins | 1 | 2021 | 31 | 0.180 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.180 |
Why?
| | Vascular Malformations | 1 | 2021 | 51 | 0.180 |
Why?
| | Electric Power Supplies | 1 | 2021 | 51 | 0.180 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 21 | 0.180 |
Why?
| | Pediatrics | 1 | 2009 | 1074 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2019 | 3384 | 0.180 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2025 | 739 | 0.170 |
Why?
| | Heart Neoplasms | 1 | 2021 | 50 | 0.170 |
Why?
| | Portal Vein | 1 | 2021 | 108 | 0.170 |
Why?
| | Patient Compliance | 1 | 2024 | 568 | 0.170 |
Why?
| | Sarcopenia | 1 | 2021 | 74 | 0.160 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 79 | 0.160 |
Why?
| | Follow-Up Studies | 4 | 2021 | 4896 | 0.160 |
Why?
| | Gastric Bypass | 1 | 2021 | 108 | 0.160 |
Why?
| | Pulmonary Circulation | 2 | 2019 | 431 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 106 | 0.160 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.160 |
Why?
| | Sensitivity and Specificity | 3 | 2024 | 1847 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 208 | 0.160 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 13 | 0.160 |
Why?
| | Kidney | 3 | 2022 | 1383 | 0.160 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2020 | 127 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 192 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2018 | 39 | 0.150 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 18 | 0.150 |
Why?
| | Eating | 1 | 2021 | 372 | 0.150 |
Why?
| | Cloaca | 1 | 2018 | 48 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 244 | 0.150 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 52 | 0.150 |
Why?
| | Sleep | 1 | 2024 | 689 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 126 | 0.150 |
Why?
| | Shear Strength | 1 | 2018 | 67 | 0.140 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 103 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| | Liver Function Tests | 1 | 2018 | 112 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2021 | 242 | 0.140 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 19 | 0.140 |
Why?
| | Prospective Studies | 7 | 2024 | 7158 | 0.140 |
Why?
| | Stroke Volume | 4 | 2022 | 593 | 0.140 |
Why?
| | Cholangitis, Sclerosing | 1 | 2018 | 71 | 0.140 |
Why?
| | Blood Vessels | 1 | 2018 | 187 | 0.140 |
Why?
| | Perfusion | 1 | 2017 | 197 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2444 | 0.130 |
Why?
| | Prognosis | 5 | 2021 | 3773 | 0.130 |
Why?
| | Thoracic Diseases | 1 | 2016 | 14 | 0.130 |
Why?
| | Vascular Remodeling | 1 | 2018 | 192 | 0.130 |
Why?
| | Dilatation, Pathologic | 3 | 2024 | 60 | 0.130 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.130 |
Why?
| | Systole | 3 | 2022 | 191 | 0.130 |
Why?
| | Quality Improvement | 1 | 2024 | 1112 | 0.130 |
Why?
| | Prevalence | 1 | 2023 | 2564 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 219 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2022 | 541 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 896 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 281 | 0.120 |
Why?
| | Age Factors | 5 | 2024 | 3161 | 0.120 |
Why?
| | Mutation | 2 | 2024 | 3706 | 0.120 |
Why?
| | Adult | 11 | 2025 | 35634 | 0.120 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 24 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 526 | 0.120 |
Why?
| | Metformin | 1 | 2018 | 316 | 0.120 |
Why?
| | Calcinosis | 1 | 2017 | 233 | 0.120 |
Why?
| | Exercise Test | 1 | 2017 | 614 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2017 | 672 | 0.110 |
Why?
| | Risk Assessment | 4 | 2018 | 3269 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5437 | 0.110 |
Why?
| | Photons | 2 | 2024 | 67 | 0.110 |
Why?
| | Research Design | 1 | 2020 | 1045 | 0.110 |
Why?
| | Toes | 1 | 2014 | 15 | 0.110 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 28 | 0.110 |
Why?
| | Liver Transplantation | 1 | 2021 | 833 | 0.110 |
Why?
| | Disease Progression | 2 | 2018 | 2628 | 0.110 |
Why?
| | Edema | 1 | 2014 | 124 | 0.100 |
Why?
| | Ligation | 1 | 2012 | 87 | 0.100 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 29 | 0.100 |
Why?
| | Comorbidity | 1 | 2017 | 1551 | 0.100 |
Why?
| | Reference Values | 2 | 2024 | 796 | 0.100 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1560 | 0.100 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2012 | 49 | 0.100 |
Why?
| | Gadolinium DTPA | 1 | 2012 | 51 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5085 | 0.090 |
Why?
| | Barium Sulfate | 1 | 2011 | 15 | 0.090 |
Why?
| | Lung | 2 | 2023 | 3940 | 0.090 |
Why?
| | Biomechanical Phenomena | 3 | 2020 | 766 | 0.090 |
Why?
| | North America | 2 | 2022 | 294 | 0.090 |
Why?
| | Bronchi | 1 | 2012 | 249 | 0.090 |
Why?
| | Colonography, Computed Tomographic | 1 | 2010 | 6 | 0.090 |
Why?
| | American Heart Association | 2 | 2022 | 300 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 680 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1221 | 0.080 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 36 | 0.080 |
Why?
| | Glomerulonephritis, IGA | 1 | 2009 | 10 | 0.080 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 256 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 31177 | 0.070 |
Why?
| | Myocardial Contraction | 2 | 2020 | 335 | 0.070 |
Why?
| | Adnexal Diseases | 1 | 2008 | 2 | 0.070 |
Why?
| | Ovarian Cysts | 1 | 2008 | 6 | 0.070 |
Why?
| | Age Determination by Skeleton | 1 | 2008 | 17 | 0.070 |
Why?
| | Bacteremia | 1 | 2010 | 194 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 6423 | 0.070 |
Why?
| | Pericardial Effusion | 1 | 2008 | 21 | 0.070 |
Why?
| | Thyroid Hormones | 1 | 2008 | 55 | 0.070 |
Why?
| | Pleural Effusion | 1 | 2008 | 51 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1021 | 0.070 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 168 | 0.070 |
Why?
| | Thyroid Gland | 1 | 2008 | 95 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 338 | 0.070 |
Why?
| | Pelvis | 1 | 2008 | 104 | 0.070 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 165 | 0.070 |
Why?
| | Puberty | 1 | 2008 | 143 | 0.070 |
Why?
| | Carbon Footprint | 1 | 2025 | 2 | 0.060 |
Why?
| | Hemorrhage | 1 | 2009 | 680 | 0.060 |
Why?
| | Blood Circulation | 1 | 2024 | 41 | 0.060 |
Why?
| | Motion | 1 | 2025 | 98 | 0.060 |
Why?
| | Time Factors | 3 | 2021 | 6550 | 0.050 |
Why?
| | Risk Factors | 4 | 2021 | 9801 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 66 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 103 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 157 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 98 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 30 | 0.050 |
Why?
| | Observer Variation | 1 | 2023 | 314 | 0.050 |
Why?
| | Climate Change | 1 | 2025 | 159 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 287 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2739 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2024 | 309 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 791 | 0.050 |
Why?
| | United States | 3 | 2024 | 13913 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.050 |
Why?
| | Creatinine | 1 | 2022 | 490 | 0.040 |
Why?
| | Iron-Binding Proteins | 1 | 2000 | 40 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 66 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 980 | 0.040 |
Why?
| | Norwood Procedures | 1 | 2020 | 29 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 622 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 128 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1708 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 1013 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 39 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 54 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 2000 | 131 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 190 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 148 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1877 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 673 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 238 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 3971 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 42 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 711 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2646 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 90 | 0.040 |
Why?
| | Societies, Medical | 1 | 2022 | 759 | 0.040 |
Why?
| | Biliary Tract | 1 | 2018 | 15 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 150 | 0.040 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 16 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1201 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 79 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2019 | 136 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 371 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1597 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 458 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1617 | 0.030 |
Why?
| | Cardiac Output | 1 | 2017 | 157 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 497 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 741 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1368 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 916 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 118 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 222 | 0.030 |
Why?
| | Triplets | 1 | 2012 | 3 | 0.030 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 16 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1736 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 262 | 0.020 |
Why?
| | Angiography | 1 | 2012 | 197 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2012 | 219 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 443 | 0.020 |
Why?
| | Cesarean Section | 1 | 2012 | 183 | 0.020 |
Why?
| | Airway Obstruction | 1 | 2012 | 154 | 0.020 |
Why?
| | Ireland | 1 | 2010 | 27 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1168 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2274 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 542 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 290 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2009 | 83 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1839 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1368 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2885 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 403 | 0.020 |
Why?
| | Aged | 2 | 2019 | 22107 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 482 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2009 | 423 | 0.020 |
Why?
| | COS Cells | 1 | 2000 | 186 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 143 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 360 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 541 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7066 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 918 | 0.010 |
Why?
| | Rats | 1 | 2000 | 5487 | 0.010 |
Why?
| | Mice | 1 | 2000 | 16983 | 0.000 |
Why?
| | Animals | 1 | 2000 | 35409 | 0.000 |
Why?
|
|
Browne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|